Metabolic Dysfunction and Peroxisome Proliferator-Activated Receptors (PPAR) in Multiple Sclerosis

por Ferret-Sena, Véronique, Capela, Carlos, Sena, Armando
Publicado 2018

Serum Lipoprotein Profile Is Associated With Protective Effects of Oral Contraceptive Use on Multiple Sclerosis Severity: A Cross-Sectional Study

por Sena, Armando, Macedo, Ana, Ferret-Sena, Véronique, Capela, Carlos, Pedrosa, Rui
Publicado 2019

Fingolimod treatment modulates PPARγ and CD36 gene expression in women with multiple sclerosis

por Ferret-Sena, Véronique, Capela, Carlos, Macedo, Ana, Salgado, António Vasco, Derudas, Bruno, Staels, Bart, Sena, Armando
Publicado 2022

Natalizumab Treatment Modulates Peroxisome Proliferator-Activated Receptors Expression in Women with Multiple Sclerosis

por Ferret-Sena, Véronique, Maia e Silva, Alexandra, Sena, Armando, Cavaleiro, Inês, Vale, José, Derudas, Bruno, Chinetti-Gbaguidi, Giulia, Staels, Bart
Publicado 2016